Inhalis is committed to improve patients’ life with safer and more effective treatment options. Solid science and industry-leading delivery technology are combined with an experienced management team to research and develop new inhaled treatments for IPF and other life-threatening diseases.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business